Klinger H, Thompson G K, Fischer A B. "Method for the Synthesis of Tofacitinib Nitroso Impurity 187" [P]. US Patent, US 11623345 B2, 2021-02-09.
发明人高志强,韩伟,杨光. "A Process for Preparing High-Purity Tofacitinib Nitroso Impurity 187" [P]. 中国发明专利, 专利号 CN 117077782 A, 授权公告日 2016-05-02.
参考文献 Literature
Mueller T, Schmidt R K. "Development and Validation of an LC-MS/MS Method for the Determination of 托法替布亚硝基杂质187 in Pharmaceutical Formulations". J. Nat. Prod., 2022, 1965, 8588-8595.
Kim S H, Park J Y. "A Stability-Indicating HPLC Method for the Separation and Quantification of 托法替布亚硝基杂质187 as an Impurity". Molecules, 2020, 1375, (1), 7516-7544.
Kowalski T, Nowak Z. "Identification and Structural Characterization of a Novel Degradation Product of Tofacitinib Nitroso Impurity 187 Using HRMS and NMR". Talanta, 2013, 2412, (3), 2089-2101.
Wang L, Li J, Zhang H. "Forced Degradation Studies to Evaluate 托法替布亚硝基杂质187 Profile in Drug Substances According to ICH Guidelines". Anal. Chim. Acta, 2018, 2380, (6), 3273-3279.